Annual EBITDA
$4.25B$411.00M-8.83%
Summary
- Current Value
- As of today, REGN annual EBITDA is $4.25B, down -8.83% on
- Historical Performance
- REGN annual EBITDA is down -25.87% over the past 3 years, up +11.36% over the past 5 years
- All-Time High Comparison
- REGN annual EBITDA is currently -54.02% below its historical high of $9.23B set on
- 3-Year Low Comparison
- REGN annual EBITDA is at its 3-year low
- Sector Comparison
- REGN annual EBITDA is higher than 97.34% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $4.25B | -8.8% | -25.9% | +11.4% | +5558.3% | |
| Quarterly EBITDA | $2.19B | +75.7% | +66.4% | +14.1% | +4465.6% | |
| TTM EBITDA | $5.65B | +29.6% | +14.0% | -27.1% | +4040.6% | |
| Price | $904.35 | +37.5% | +13.0% | +46.7% | +1572.9% | |
| PE Ratio | 19.96 | +26.8% | -12.5% | +102.8% | – | |
| Annual Revenue | $14.34B | +1.0% | +17.8% | +68.8% | +3024.3% | |
| Annual EPS | $41.48 | +8.2% | +8.5% | +35.9% | +3392.2% | |
| $3.69B | -11.5% | -31.4% | +3.3% | +3888.6% | ||
| Annual Net Income | $4.50B | +2.1% | +3.8% | +28.2% | +4412.2% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $5.73B | N/A | -25.9% |
| 5Y | $9.23B | -54.0% | |
| All | $9.23B | -54.0% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $4.25B | at low | |
| 5Y | $3.81B | N/A | +11.4% |
| All | -$174.08M | +2539.0% |
EBITDA History
FAQ
- What is the current annual EBITDA of REGN?
- As of today, REGN annual EBITDA is $4.25B
- What is 1-year change in REGN annual EBITDA?
- REGN annual EBITDA is down -8.83% year-over-year
- What is 3-year change in REGN annual EBITDA?
- REGN annual EBITDA is down -25.87% over the past 3 years
- How far is REGN annual EBITDA from its all-time high?
- REGN annual EBITDA is currently -54.02% below its historical high of $9.23B set on December 31, 2021
- How does REGN annual EBITDA rank versus sector peers?
- REGN annual EBITDA is higher than 97.34% of companies in Healthcare sector
- When is REGN next annual earnings release?
- The next annual earnings release for REGN is on
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$2.19B$646.50M+41.87%
Summary
- Current Value
- As of today, REGN quarterly EBITDA is $2.19B, up +41.87% on
- Historical Performance
- REGN quarterly EBITDA is up +75.73% year-over-year, up +66.42% over the past 3 years
- All-Time High Comparison
- REGN quarterly EBITDA is currently -35.91% below its historical high of $3.42B set on
- 3-Year Low Comparison
- REGN quarterly EBITDA is +199.73% above its 3-year low of $730.90M reached on
- Sector Comparison
- REGN quarterly EBITDA is higher than 97.98% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $2.19B | +41.9% | +75.7% | +66.4% | +14.1% | |
| Annual EBITDA | $4.25B | – | -8.8% | -25.9% | +11.4% | |
| TTM EBITDA | $5.65B | +20.1% | +29.6% | +14.0% | -27.1% | |
| Price | $904.35 | +15.3% | +37.5% | +13.0% | +46.7% | |
| PE Ratio | 19.96 | +3.0% | +26.8% | -12.5% | +102.8% | |
| Quarterly Revenue | $5.12B | +19.2% | +36.3% | +52.1% | +48.2% | |
| Quarterly EPS | $18.45 | +50.8% | +35.5% | +107.6% | +28.8% | |
| $2.07B | +45.7% | +86.5% | +70.9% | +12.1% | ||
| Quarterly Net Income | $1.95B | +50.3% | +33.5% | +93.4% | +19.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.19B | at high | |
| 3Y | $2.19B | at high | |
| 5Y | $2.71B | -19.3% | |
| All | $3.42B | -35.9% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $868.00M | +152.4% | |
| 3Y | $730.90M | +199.7% | |
| 5Y | $730.90M | +199.7% | |
| All | -$52.42M | +4279.4% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of REGN?
- As of today, REGN quarterly EBITDA is $2.19B
- What is REGN quarterly EBITDA most recent change?
- REGN quarterly EBITDA was up +41.87% on September 30, 2026
- What is 1-year change in REGN quarterly EBITDA?
- REGN quarterly EBITDA is up +75.73% year-over-year
- How far is REGN quarterly EBITDA from its all-time high?
- REGN quarterly EBITDA is currently -35.91% below its historical high of $3.42B set on June 30, 2021
- How does REGN quarterly EBITDA rank versus sector peers?
- REGN quarterly EBITDA is higher than 97.98% of companies in Healthcare sector
- When is REGN next earnings release?
- The next earnings release for REGN is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$5.65B$944.10M+20.08%
Summary
- Current Value
- As of today, REGN TTM EBITDA is $5.65B, up +20.08% on
- Historical Performance
- REGN TTM EBITDA is up +29.65% year-over-year, up +13.98% over the past 3 years
- All-Time High Comparison
- REGN TTM EBITDA is currently -40.02% below its historical high of $9.41B set on
- 3-Year Low Comparison
- REGN TTM EBITDA is +32.99% above its 3-year low of $4.25B reached on
- Sector Comparison
- REGN TTM EBITDA is higher than 97.41% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $5.65B | +20.1% | +29.6% | +14.0% | -27.1% | |
| Annual EBITDA | $4.25B | – | -8.8% | -25.9% | +11.4% | |
| Quarterly EBITDA | $2.19B | +41.9% | +75.7% | +66.4% | +14.1% | |
| Price | $904.35 | +15.3% | +37.5% | +13.0% | +46.7% | |
| PE Ratio | 19.96 | +3.0% | +26.8% | -12.5% | +102.8% | |
| TTM Revenue | $16.90B | +8.8% | +18.6% | +29.0% | +24.8% | |
| TTM EPS | $45.30 | +11.9% | +8.4% | +29.2% | -27.7% | |
| $5.13B | +23.0% | +34.0% | +12.9% | -31.3% | ||
| TTM Net Income | $4.82B | +11.3% | +5.2% | +20.7% | -31.1% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $5.65B | at high | |
| 3Y | $5.65B | at high | |
| 5Y | $9.41B | -40.0% | |
| All | $9.41B | -40.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.25B | +33.0% | |
| 3Y | $4.25B | +33.0% | |
| 5Y | $4.25B | +33.0% | |
| All | -$174.08M | +3343.7% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of REGN?
- As of today, REGN TTM EBITDA is $5.65B
- What is REGN TTM EBITDA most recent change?
- REGN TTM EBITDA was up +20.08% on September 30, 2026
- What is 1-year change in REGN TTM EBITDA?
- REGN TTM EBITDA is up +29.65% year-over-year
- How far is REGN TTM EBITDA from its all-time high?
- REGN TTM EBITDA is currently -40.02% below its historical high of $9.41B set on March 31, 2022
- How does REGN TTM EBITDA rank versus sector peers?
- REGN TTM EBITDA is higher than 97.41% of companies in Healthcare sector
- When is REGN next earnings release?
- The next earnings release for REGN is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- REGN Official Website www.regeneron.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm
- REGN Profile on Yahoo Finance finance.yahoo.com/quote/REGN
- REGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/regn